Annual Total Liabilities
$172.60 M
+$95.32 M+123.35%
December 31, 2022
Summary
- As of February 26, 2025, EGRX annual total liabilities is $172.60 million, with the most recent change of +$95.32 million (+123.35%) on December 31, 2022.
- During the last 3 years, EGRX annual total liabilities has risen by +$97.22 million (+128.97%).
- EGRX annual total liabilities is now at all-time high.
Performance
EGRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$152.78 M
-$18.55 M-10.83%
June 30, 2023
Summary
- As of February 26, 2025, EGRX quarterly total liabilities is $152.78 million, with the most recent change of -$18.55 million (-10.83%) on June 30, 2023.
- Over the past year, EGRX quarterly total liabilities has increased by +$9.01 million (+6.27%).
- EGRX quarterly total liabilities is now -15.17% below its all-time high of $180.11 million, reached on March 31, 2020.
Performance
EGRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EGRX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +123.3% | +6.3% |
| 3 y3 years | +129.0% | +110.0% |
| 5 y5 years | +89.8% | +73.2% |
EGRX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +123.3% | -11.5% | +97.7% |
| 5 y | 5-year | at high | +156.9% | -15.2% | +127.4% |
| alltime | all time | at high | +975.5% | -15.2% | +852.0% |
Eagle Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $152.78 M(-10.8%) |
| Mar 2023 | - | $171.33 M(-0.7%) |
| Dec 2022 | $172.60 M(+123.3%) | $172.60 M(+11.6%) |
| Sep 2022 | - | $154.67 M(+7.6%) |
| Jun 2022 | - | $143.77 M(+38.0%) |
| Mar 2022 | - | $104.20 M(+34.8%) |
| Dec 2021 | $77.28 M(+15.0%) | $77.28 M(+8.9%) |
| Sep 2021 | - | $70.97 M(+2.3%) |
| Jun 2021 | - | $69.39 M(+0.7%) |
| Mar 2021 | - | $68.89 M(+2.5%) |
| Dec 2020 | $67.18 M(-10.9%) | $67.18 M(-10.9%) |
| Sep 2020 | - | $75.37 M(+3.6%) |
| Jun 2020 | - | $72.75 M(-59.6%) |
| Mar 2020 | - | $180.11 M(+138.9%) |
| Dec 2019 | $75.38 M(-3.2%) | $75.38 M(-7.3%) |
| Sep 2019 | - | $81.27 M(-8.8%) |
| Jun 2019 | - | $89.15 M(+6.0%) |
| Mar 2019 | - | $84.09 M(+8.0%) |
| Dec 2018 | $77.84 M | $77.84 M(+4.2%) |
| Sep 2018 | - | $74.72 M(-15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $88.21 M(+24.0%) |
| Mar 2018 | - | $71.12 M(-21.8%) |
| Dec 2017 | $90.92 M(+44.1%) | $90.92 M(-5.1%) |
| Sep 2017 | - | $95.81 M(+74.8%) |
| Jun 2017 | - | $54.82 M(-5.5%) |
| Mar 2017 | - | $57.99 M(-8.1%) |
| Dec 2016 | $63.09 M(+84.2%) | $63.09 M(+53.1%) |
| Sep 2016 | - | $41.20 M(-0.8%) |
| Jun 2016 | - | $41.53 M(+14.1%) |
| Mar 2016 | - | $36.38 M(+6.2%) |
| Dec 2015 | $34.26 M(+68.7%) | $34.26 M(-0.9%) |
| Sep 2015 | - | $34.59 M(+40.7%) |
| Jun 2015 | - | $24.58 M(-9.1%) |
| Mar 2015 | - | $27.05 M(+21.9%) |
| Dec 2014 | - | $22.19 M(+9.2%) |
| Sep 2014 | $20.32 M(+26.6%) | $20.32 M(+25.0%) |
| Jun 2014 | - | $16.25 M(-15.7%) |
| Mar 2014 | - | $19.27 M(+11.8%) |
| Dec 2013 | - | $17.24 M(+7.4%) |
| Sep 2013 | $16.05 M(-25.5%) | $16.05 M |
| Sep 2012 | $21.54 M | - |
FAQ
- What is Eagle Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals annual total liabilities year-on-year change?
- What is Eagle Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eagle Pharmaceuticals?
- What is Eagle Pharmaceuticals quarterly total liabilities year-on-year change?
What is Eagle Pharmaceuticals annual total liabilities?
The current annual total liabilities of EGRX is $172.60 M
What is the all time high annual total liabilities for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high annual total liabilities is $172.60 M
What is Eagle Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, EGRX annual total liabilities has changed by +$95.32 M (+123.35%)
What is Eagle Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of EGRX is $152.78 M
What is the all time high quarterly total liabilities for Eagle Pharmaceuticals?
Eagle Pharmaceuticals all-time high quarterly total liabilities is $180.11 M
What is Eagle Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, EGRX quarterly total liabilities has changed by +$9.01 M (+6.27%)